Cargando…
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to 3.8 per 100,000 people. Weakening and gradual atrophy of the voluntary muscles are the first signs of the disease ons...
Autores principales: | Najafi, Shahrzad, Najafi, Parizad, Kaffash Farkhad, Najmeh, Hosseini Torshizi, Ghazal, Assaran Darban, Reza, Boroumand, Amir Reza, Sahab-Negah, Sajad, Khodadoust, Mohammad Ali, Tavakol-Afshari, Jalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329242/ https://www.ncbi.nlm.nih.gov/pubmed/37427325 http://dx.doi.org/10.22038/IJBMS.2023.66364.14572 |
Ejemplares similares
-
Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis
por: Tavakol-Afshari, Jalil, et al.
Publicado: (2021) -
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2022) -
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2021) -
Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation
por: Sadeghi Moghadam, Majid, et al.
Publicado: (2023) -
The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
por: Korfi, Faranak, et al.
Publicado: (2021)